{"id":3211,"date":"2023-05-09T16:04:08","date_gmt":"2023-05-09T14:04:08","guid":{"rendered":"https:\/\/docuply.io\/what-is-a-pre-ind-meeting\/"},"modified":"2025-12-22T15:56:18","modified_gmt":"2025-12-22T14:56:18","slug":"what-is-a-pre-ind-meeting","status":"publish","type":"page","link":"https:\/\/docuply.io\/en\/what-is-a-pre-ind-meeting\/","title":{"rendered":"What is a Pre-IND Meeting?"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Docuply\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

As a pharmaceutical or biotech start-up, one of the most important steps in bringing a new drug to market is the pre-IND meeting. This meeting, which takes place between the start-up and the FDA or EMA, is an opportunity to discuss the proposed drug development programme and receive feedback from the FDA or EMA on the planned IND application. <\/p>\n

One of the most important aspects of the pre-IND meeting is preparation. It is important that you come to the meeting with a well-prepared and organised presentation that clearly outlines your planned drug development programme. This includes information about your preclinical data, the planned design of the clinical trial, and your plans for manufacturing and quality control. Proper document management is essential for compiling the required preclinical data and quality management. Electronic document management systems such as Docuply<\/a> can help here. Another important aspect of the pre-IND meeting is communication. It is important to communicate clearly and effectively with the FDA or EMA during the meeting and to be open and transparent about your plans and any potential challenges or concerns. It is also important to listen carefully to the feedback from the authorities and to take their comments and suggestions into account as you continue to develop your drug development programme. <\/p>\n

With regard to the pre-IND meeting, it is also important to mention regulatory compliance. The FDA and EMA have strict guidelines for IND applications, and it is essential to ensure that your proposed drug development programme complies with these guidelines. This may require close collaboration with regulatory experts to ensure that your plans are consistent with the requirements of the authorities. Financing is also an important aspect for pharmaceutical or biotech start-ups in connection with the pre-IND meeting. Developing a new drug can be a costly process, and it is crucial that you have sufficient financial resources to support your development programme. This includes presenting investors with a solid business plan and demonstrating the potential value of your drug.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

With Docuply, you can move smoothly and GLP-compliantly from preclinical studies to clinical studies with your third parties.<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tBook or watch a product demo<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Finally, time management is an important aspect of the pre-IND meeting. The IND application process can take several months, and it is important to plan ahead and allow sufficient time for each step of the process. This may include setting realistic timelines and milestones and ensuring that all team members are aware of their responsibilities. In summary, the pre-IND meeting is an essential step in bringing a new drug to market as a pharmaceutical or biotech start-up. By being well prepared, communicating effectively with the authorities, ensuring compliance, securing funding and using your time effectively, you can successfully navigate this process and move your new drug into clinical trials.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Test all the advantages of a digital document management system specially developed for the pharmaceutical and biotech industry now without obligation. You can get started in just five minutes, convince yourself.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tTry Docuply now for free<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Quality management in the pharmaceutical and biotech industry: Current challenges in the cooperation between pharmaceutical companies and CROs, CMOs and CDMOs<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tDownload free whitepaper<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

As a pharmaceutical or biotech start-up, one of the most important steps in bringing a new drug to market is the pre-IND meeting. This meeting, which takes place between the start-up and the FDA or EMA, is an opportunity to … Read More<\/a><\/p>\n","protected":false},"author":2,"featured_media":3205,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3211","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nWhat is a Pre-IND Meeting? | Docuply<\/title>\n<meta name=\"description\" content=\"As a pharmaceutical or biotech start-up, one of the most important steps in bringing a new drug to market is the pre-IND meeting.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/docuply.io\/en\/what-is-a-pre-ind-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What is a Pre-IND Meeting? | Docuply\" \/>\n<meta property=\"og:description\" content=\"As a pharmaceutical or biotech start-up, one of the most important steps in bringing a new drug to market is the pre-IND meeting.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/docuply.io\/en\/what-is-a-pre-ind-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Docuply\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-22T14:56:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/docuply.io\/wp-content\/uploads\/2023\/01\/Herausforderungen-bei-der-Zusammenarbeit-mit-CROs-CMOs-und-CDMOs-1024x576.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/docuply.io\/wp-content\/uploads\/2023\/01\/Herausforderungen-bei-der-Zusammenarbeit-mit-CROs-CMOs-und-CDMOs-1024x576.jpg\" \/>\n<meta name=\"twitter:site\" content=\"@docuplyio\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/what-is-a-pre-ind-meeting\\\/\",\"url\":\"https:\\\/\\\/docuply.io\\\/en\\\/what-is-a-pre-ind-meeting\\\/\",\"name\":\"What is a Pre-IND Meeting? | Docuply\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/what-is-a-pre-ind-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/what-is-a-pre-ind-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/docuply.io\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/Docuply-Herausforderungen-rund-um-das-Pre-IND-Filling-fuer-Biotech-und-Pharma-Start-Ups.jpg\",\"datePublished\":\"2023-05-09T14:04:08+00:00\",\"dateModified\":\"2025-12-22T14:56:18+00:00\",\"description\":\"As a pharmaceutical or biotech start-up, one of the most important steps in bringing a new drug to market is the pre-IND meeting.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/what-is-a-pre-ind-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/docuply.io\\\/en\\\/what-is-a-pre-ind-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/what-is-a-pre-ind-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/docuply.io\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/Docuply-Herausforderungen-rund-um-das-Pre-IND-Filling-fuer-Biotech-und-Pharma-Start-Ups.jpg\",\"contentUrl\":\"https:\\\/\\\/docuply.io\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/Docuply-Herausforderungen-rund-um-das-Pre-IND-Filling-fuer-Biotech-und-Pharma-Start-Ups.jpg\",\"width\":1920,\"height\":935,\"caption\":\"Docuply - Herausforderungen rund um das Pre-IND-Filling f\u00fcr Biotech- und Pharma-Start-Ups\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/what-is-a-pre-ind-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/docuply.io\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What is a Pre-IND Meeting?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/docuply.io\\\/en\\\/\",\"name\":\"Docuply\",\"description\":\"Das elektronische Qualit\u00e4ts\u00admanagement\u00adsystem f\u00fcr Pharma-\u00adKMU und Biotech Start-Ups\",\"publisher\":{\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/docuply.io\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/#organization\",\"name\":\"Docuply\",\"url\":\"https:\\\/\\\/docuply.io\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/docuply.io\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Docuply-Logo-1.0.svg\",\"contentUrl\":\"https:\\\/\\\/docuply.io\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Docuply-Logo-1.0.svg\",\"width\":2913,\"height\":719,\"caption\":\"Docuply\"},\"image\":{\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/docuplyio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/docuply\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What is a Pre-IND Meeting? | Docuply","description":"As a pharmaceutical or biotech start-up, one of the most important steps in bringing a new drug to market is the pre-IND meeting.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/docuply.io\/en\/what-is-a-pre-ind-meeting\/","og_locale":"en_US","og_type":"article","og_title":"What is a Pre-IND Meeting? | Docuply","og_description":"As a pharmaceutical or biotech start-up, one of the most important steps in bringing a new drug to market is the pre-IND meeting.","og_url":"https:\/\/docuply.io\/en\/what-is-a-pre-ind-meeting\/","og_site_name":"Docuply","article_modified_time":"2025-12-22T14:56:18+00:00","og_image":[{"url":"https:\/\/docuply.io\/wp-content\/uploads\/2023\/01\/Herausforderungen-bei-der-Zusammenarbeit-mit-CROs-CMOs-und-CDMOs-1024x576.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_image":"https:\/\/docuply.io\/wp-content\/uploads\/2023\/01\/Herausforderungen-bei-der-Zusammenarbeit-mit-CROs-CMOs-und-CDMOs-1024x576.jpg","twitter_site":"@docuplyio","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/docuply.io\/en\/what-is-a-pre-ind-meeting\/","url":"https:\/\/docuply.io\/en\/what-is-a-pre-ind-meeting\/","name":"What is a Pre-IND Meeting? | Docuply","isPartOf":{"@id":"https:\/\/docuply.io\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/docuply.io\/en\/what-is-a-pre-ind-meeting\/#primaryimage"},"image":{"@id":"https:\/\/docuply.io\/en\/what-is-a-pre-ind-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/docuply.io\/wp-content\/uploads\/2023\/05\/Docuply-Herausforderungen-rund-um-das-Pre-IND-Filling-fuer-Biotech-und-Pharma-Start-Ups.jpg","datePublished":"2023-05-09T14:04:08+00:00","dateModified":"2025-12-22T14:56:18+00:00","description":"As a pharmaceutical or biotech start-up, one of the most important steps in bringing a new drug to market is the pre-IND meeting.","breadcrumb":{"@id":"https:\/\/docuply.io\/en\/what-is-a-pre-ind-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/docuply.io\/en\/what-is-a-pre-ind-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/docuply.io\/en\/what-is-a-pre-ind-meeting\/#primaryimage","url":"https:\/\/docuply.io\/wp-content\/uploads\/2023\/05\/Docuply-Herausforderungen-rund-um-das-Pre-IND-Filling-fuer-Biotech-und-Pharma-Start-Ups.jpg","contentUrl":"https:\/\/docuply.io\/wp-content\/uploads\/2023\/05\/Docuply-Herausforderungen-rund-um-das-Pre-IND-Filling-fuer-Biotech-und-Pharma-Start-Ups.jpg","width":1920,"height":935,"caption":"Docuply - Herausforderungen rund um das Pre-IND-Filling f\u00fcr Biotech- und Pharma-Start-Ups"},{"@type":"BreadcrumbList","@id":"https:\/\/docuply.io\/en\/what-is-a-pre-ind-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/docuply.io\/en\/"},{"@type":"ListItem","position":2,"name":"What is a Pre-IND Meeting?"}]},{"@type":"WebSite","@id":"https:\/\/docuply.io\/en\/#website","url":"https:\/\/docuply.io\/en\/","name":"Docuply","description":"Das elektronische Qualit\u00e4ts\u00admanagement\u00adsystem f\u00fcr Pharma-\u00adKMU und Biotech Start-Ups","publisher":{"@id":"https:\/\/docuply.io\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/docuply.io\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/docuply.io\/en\/#organization","name":"Docuply","url":"https:\/\/docuply.io\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/docuply.io\/en\/#\/schema\/logo\/image\/","url":"https:\/\/docuply.io\/wp-content\/uploads\/2021\/12\/Docuply-Logo-1.0.svg","contentUrl":"https:\/\/docuply.io\/wp-content\/uploads\/2021\/12\/Docuply-Logo-1.0.svg","width":2913,"height":719,"caption":"Docuply"},"image":{"@id":"https:\/\/docuply.io\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/docuplyio","https:\/\/www.linkedin.com\/company\/docuply\/"]}]}},"_links":{"self":[{"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/pages\/3211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/comments?post=3211"}],"version-history":[{"count":2,"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/pages\/3211\/revisions"}],"predecessor-version":[{"id":4939,"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/pages\/3211\/revisions\/4939"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/media\/3205"}],"wp:attachment":[{"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/media?parent=3211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}